Filter News
Area of Research
- (-) Fuel Cycle Science and Technology (1)
- (-) Materials (20)
- Advanced Manufacturing (2)
- Biology and Environment (5)
- Clean Energy (14)
- Computer Science (1)
- Fusion and Fission (1)
- Isotopes (1)
- Materials for Computing (1)
- National Security (2)
- Neutron Science (10)
- Nuclear Science and Technology (8)
- Supercomputing (16)
News Topics
- (-) Bioenergy (3)
- (-) Biomedical (1)
- (-) Computer Science (5)
- (-) Machine Learning (1)
- (-) Materials Science (15)
- (-) Nuclear Energy (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (1)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Critical Materials (2)
- Energy Storage (4)
- Environment (2)
- Isotopes (3)
- Materials (1)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (1)
- Neutron Science (9)
- Physics (6)
- Polymers (2)
- Quantum Science (4)
- Summit (1)
- Sustainable Energy (4)
- Transportation (1)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.